Abstract
s / Biol Blood Marrow Transplant 20 (2014) S45eS56 S54 results suggest that post-transplant IL-22 administration represents a novel strategy to reduce gut GVHD by direct protection of intestinal epitheliumwithout limiting immune function post-transplant.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
